Myriad Genetics
MYGN
#6655
Rank
ยฃ0.51 B
Marketcap
ยฃ5.53
Share price
3.96%
Change (1 day)
-52.66%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ0.54 Billion

According to Myriad Genetics's latest financial reports the company's total assets are ยฃ0.54 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ0.81 B-9.01%
2023-12-31ยฃ0.89 B-9.17%
2022-12-31ยฃ0.99 B1.27%
2021-12-31ยฃ0.97 B
2020-06-30ยฃ1.13 B-7.9%
2019-06-30ยฃ1.23 B38.35%
2018-06-30ยฃ0.88 B-4.26%
2017-06-30ยฃ0.92 B40.69%
2016-06-30ยฃ0.66 B35.25%
2015-06-30ยฃ0.48 B1.44%
2014-06-30ยฃ0.48 B-8.93%
2013-06-30ยฃ0.52 B20.09%
2012-06-30ยฃ0.44 B15.65%
2011-06-30ยฃ0.38 B-2.8%
2010-06-30ยฃ0.39 B38.35%
2009-06-30ยฃ0.28 B12.82%
2008-06-30ยฃ0.25 B33.74%
2007-06-30ยฃ0.18 B23.99%
2006-06-30ยฃ0.15 B68.36%
2005-06-30ยฃ89.86 M-13.16%
2004-06-30ยฃ0.10 B-6.69%
2003-06-30ยฃ0.11 B7.99%
2002-06-30ยฃ0.10 B-15.57%
2001-06-30ยฃ0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
ยฃ7.28 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
ยฃ4.43 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
ยฃ16.61 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ5.72 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ63.28 B 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA